TPI
GILD icon

Trust Point Inc’s Gilead Sciences GILD Stock Holding History

Trust Point Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$443K Buy
3,505
+342
+11% +$45.1K 0.04% 248
2026
Q1 		$441K Buy
3,163
+49
+2% +$6.86K 0.04% 285
2025
Q4 		$382K Buy
3,114
+68
+2% +$8.26K 0.03% 302
2025
Q3 		$338K Sell
3,046
-1,485
-33% -$169K 0.03% 334
2025
Q2 		$502K Buy
4,531
+1,495
+49% +$159K 0.05% 188
2025
Q1 		$340K Sell
3,036
-1,177
-28% -$121K 0.03% 309
2024
Q4 		$389K Buy
4,213
+169
+4% +$15.2K 0.03% 352
2024
Q3 		$339K Buy
4,044
+565
+16% +$43.1K 0.03% 361
2024
Q2 		$239K Sell
3,479
-339
-9% -$22.6K 0.02% 438
2024
Q1 		$280K Sell
3,818
-683
-15% -$52.5K 0.02% 423
2023
Q4 		$365K Buy
+4,501
New +$350K 0.03% 347

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Trust Point Inc's GILD Position: Q2 2026 in Review

Trust Point Inc increased its Gilead Sciences (GILD) stake by 11% in Q2 2026, buying an estimated $45.1K and bringing the position to 3,505 shares worth $443K. The position accounts for 0.04% of the portfolio, ranked #248.

Trust Point Inc first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $502K in Q2 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Trust Point Inc held 3,505 shares of Gilead Sciences worth $443K as of Q2 2026.
  • Trust Point Inc bought 342 Gilead Sciences shares in Q2 2026, an estimated $45.1K.
  • Gilead Sciences made up 0.04% of Trust Point Inc's portfolio in Q2 2026, its #248 holding.
  • Trust Point Inc first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Trust Point Inc's Gilead Sciences position peaked at $502K in Q2 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.